Oladapo Yeku
- Oncology top 1%
- Molecular Biology top 10%
- Immunology top 5%
- Biomedical Engineering top 5%
- Genetics top 5%
- Co-authors
- Renier J. BrentjensTerence J. PurdonDavid R. SpriggsDayenne G. van LeeuwenMythili KoneruMichael A. FrohmanXinghuo LiMei Song
- Topics
- CAR-T cell therapy research (18 papers)Ovarian cancer diagnosis and treatment (17 papers)Cancer Immunotherapy and Biomarkers (15 papers)
- Cited by
- OncologyImmunologyGenetics
- Journals
- New England Journal of MedicineProceedings of the National Academy of SciencesNature Communications
- Partner nations
- United StatesJapanCanada
In The Last Decade
Oladapo Yeku
60 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 1.7k
- Molecular Biology 894
- Immunology 835
- Biomedical Engineering 586
- Genetics 451
Countries citing papers authored by Oladapo Yeku
This map shows the geographic impact of Oladapo Yeku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oladapo Yeku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oladapo Yeku more than expected).
Fields of papers citing papers by Oladapo Yeku
This network shows the impact of papers produced by Oladapo Yeku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oladapo Yeku. The network helps show where Oladapo Yeku may publish in the future.
Co-authorship network of co-authors of Oladapo Yeku
This figure shows the co-authorship network connecting the top 25 collaborators of Oladapo Yeku. A scholar is included among the top collaborators of Oladapo Yeku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oladapo Yeku. Oladapo Yeku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 3 | |
| 8 | 4 | |
| 9 | 6 | |
| 10 | 0 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | 2 | |
| 15 | 0 | |
| 16 | 24 | |
| 17 | 1 | |
| 18 | 111 | |
| 19 | Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivobreakdown → | 628 |
| 20 | 268 |
About Oladapo Yeku
Oladapo Yeku is a scholar working on Reproductive Medicine, Oncology and Immunology, having authored 70 papers that have together received 2.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (18 papers), Ovarian cancer diagnosis and treatment (17 papers) and Cancer Immunotherapy and Biomarkers (15 papers). The work is most often cited by research in Oncology (1.7k citations), Immunology (835 citations) and Genetics (451 citations). Oladapo Yeku has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Renier J. Brentjens, Terence J. Purdon, David R. Spriggs, Dayenne G. van Leeuwen, Mythili Koneru, Michael A. Frohman, Xinghuo Li, Mei Song, Sarwish Rafiq and Xiaojing Ma. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.